Sessions
Diabetes, a Growing Health Crisis in Singapore – What is the Best Animal-based Disease Model?
4:15 PM - 4:45 PM Thu
Hannes Hentze is a pre-clinical scientist and in vivo pharmacologist with work experience in academic research, biotech companies, and in the pharmaceutical industry. He is currently the Director, Study Services at the Biological Resource Centre (BRC) at A*STAR. His expertise includes preclinical oncology and diabetes mouse models, large animal models for cardiovascular disease and dyslipidemia, as well as rodent models for cell therapy applications. He has published over 30 peer-reviewed articles, reviews and book chapters in the areas of liver disease, redox regulation, stem cell therapy, diabetes, dyslipidemia, biomarkers/translational research, and oncology (H index: 26, >3,500 citations). He is teaching and co-organizing the popular course “Physiological Systems: Animal Models for Drug Development” as an Adjunct Associate Professor at NTU, Singapore.
Professional Experience
2014 - Present Director, Study Services, BRC (Biological Resource Centre), A*STAR, Singapore
2009 - 2013 Study Director/Principal Scientist, Pharmacology, Translational Medicine Research Centre (TMRC), Merck Sharp & Dohme (MSD) Singapore
2007 - 2009 Senior Research Scientist, S*BIO Pte Ltd, Singapore
2004 - 2007 Research Scientist, ES Cell International Pte Ltd, Singapore
2001 - 2004 Postdoctoral Fellow, Institute of Molecular and Cell Biology (IMCB), Singapore
1998 - 2000 PhD Degree Biology (“summa cum laude”), Department of Biochemical Pharmacology, University of Konstanz, Germany